Xeris Biopharma Holdings (XERS) EBT Margin (2020 - 2026)
Xeris Biopharma Holdings (XERS) recorded EBT Margin of -33.77% in Q2 2026, down 31.07 percentage points from -2.70% a year earlier and down 36.46 percentage points from the prior quarter.
Powered by 
Analysis
Xeris Biopharma Holdings (XERS) EBT Margin (2020 - 2026) Analysis & Trends
On a TTM basis, Xeris Biopharma Holdings' EBT Margin came in at -5.12% as of Jun 30, 2026, up 9.24 percentage points year-over-year; for FY2025, it came in at 0.19%, up 28.31 percentage points from FY2024.
- Annual EBT Margin has increased for five straight years, with a five-year change of +446.73 percentage points (FY2020 to FY2025).
- Across earlier years, EBT Margin came in at -28.12% in FY2024 (+10.62 pp), -38.74% in FY2023 (+48.41 pp), -87.15% in FY2022 (+160.33 pp) and -247.48% in FY2021 (+199.06 pp).
- The Q2 2026 figure is the lowest quarterly EBT Margin since Q3 2024.
- On a year-over-year basis, EBT Margin rose in six of the last eight quarters, with an average year-over-year change of +14.36 percentage points.
- Peak year-over-year performance for EBT Margin in the last five years was a gain of 204.14 percentage points in Q2 2022, against a drop of 65.02 percentage points in Q3 2021 at the low end.
- Per Business Quant, the preceding three quarters came in at 2.69% (Q1 2026), 12.91% (Q4 2025) and 0.83% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 26.66% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 25.18% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -4.11% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 29.63% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 18.19% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 27.53% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -131.41% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -4.34% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 41.75% |
| 10 | Xeris Biopharma Holdings | 1.71 Bn | 1.27 Bn | 79.59 Mn | -33.77% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -33.77% |
| Mar 31, 2026 | 2.69% |
| Dec 31, 2025 | 12.91% |
| Sep 30, 2025 | 0.83% |
| Jun 30, 2025 | -2.70% |
| Mar 31, 2025 | -15.34% |
| Dec 31, 2024 | -8.51% |
| Sep 30, 2024 | -35.13% |
| Jun 30, 2024 | -29.66% |
| Mar 31, 2024 | -45.95% |
| Dec 31, 2023 | -30.70% |
| Sep 30, 2023 | -25.93% |
| Jun 30, 2023 | -53.98% |
| Mar 31, 2023 | -50.71% |
| Dec 31, 2022 | -40.03% |
| Sep 30, 2022 | -74.58% |
| Jun 30, 2022 | -104.81% |
| Mar 31, 2022 | -154.59% |
| Dec 31, 2021 | -237.02% |
| Sep 30, 2021 | -235.16% |
API Access
Xeris Biopharma Holdings EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=XERS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "XERS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=XERS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();